MAXTREX |
RASUVO |
EMTEXATE PF |
METOJECT |
R-METHOTREXATE |
MEXATE-AQ |
ABITREXATE |
R-9985 |
METHYLAMINOPTERIN |
NSC-740 |
OTREXUP PFS |
TCMDC-125488 |
TCMDC-123832 |
AMETHOPTERIN |
EMT-25299 |
RHEUMATREX |
OTREXUP |
TCMDC-125858 |
EMTEXATE HIGH-POT |
MEXATE |
EBETREX |
METHOTREXATE |
TREXALL |
ZLATAL |
FOLEX |
CL-14377 |
METOTREXATO |
RASUVO® |
MTX |
ABITREXATE® |
4-AMINO-10-METHYLFOLIC ACID |
N-[4-[[(2,4-DIAMINO-6-PTERIDINYL)METHYL]METHYLAMINO]BENZOYL]-L-GLUTAMIC ACID |
METHOTREXATUM |
4-AMINO-N(10)-METHYLPTEROYLGLUTAMIC ACID |
METHOTREXAT |
MÉTHOTREXATE |
chemidplus:59-05-2 |
chembl:CHEMBL34259 |
pubchem.compound:126941 |
drugbank:00563 |
rxcui:6851 |
Drug Categories | folic acid antagonists |
Drug Categories | antirheumatic agents |
Drug Categories | abortifacient agents, nonsteroidal |
FDA Approval | approved |
Drug Class | Small molecule |
Drug Indications | DMARD |
Drug Categories | agents causing muscle toxicity |
Drug Categories | cardiotoxic antineoplastic agents |
Drug Categories | cytochrome p-450 cyp3a substrates |
Drug Categories | cytochrome p-450 cyp3a4 substrates |
Drug Categories | cytochrome p-450 cyp3a4 substrates with a narrow therapeutic index |
Drug Categories | cytochrome p-450 substrates |
Drug Categories | dermatologicals |
Drug Categories | drugs causing inadvertant photosensitivity |
Drug Categories | drugs that are mainly renally excreted |
Drug Categories | folic acid analogues |
Drug Categories | hepatotoxic agents |
Drug Categories | heterocyclic compounds, fused-ring |
Drug Categories | narrow therapeutic index drugs |
Drug Categories | nephrotoxic agents |
Drug Categories | oat1/slc22a6 inhibitors |
Drug Categories | oat3/slc22a8 inhibitors |
Drug Categories | oat3/slc22a8 substrates |
Drug Categories | oatp1b3 substrates |
Drug Categories | p-glycoprotein substrates |
Drug Categories | photosensitizing agents |
inhibitor (inhibitory) |
Novel drug target | Established target |
Trial Name | VIBEX MTX |
Specific Action of the Ligand | Inhibition |
inhibitor (inhibitory) |
Direct Interaction? | False |
Endogenous Drug? | False |
Specific Action of the Ligand | Inhibition |
Rheumatrex | Drug Brand |
METHOTREXATE | DrugBank Drug Name |
59-05-2 | CAS Number |
Drug Type | small molecule |
Drug Groups | approved |
Drug Categories | abortifacient agents |
Drug Indications | DMARD |
Drug Class | Small molecule |
FDA Approval | approved |
C642 | NCI drug code |
C642 | NCI drug code |
C642 | NCI drug code |
CHEMBL34259 | ChEMBL Drug ID |
D0SV8E | TTD Drug ID |
METHOTREXATE | GuideToPharmacology Ligand Name |
CHEMBL426 | ChEMBL Drug ID |